日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

The Landscape of Ferroptosis-Related Gene Signatures as Molecular Stratification in Triple-Negative Breast Cancer

铁死亡相关基因特征在三阴性乳腺癌分子分层中的作用

期刊:Diagnostics
影响因子:3.3
doi:10.3390/diagnostics16030379
Buta, Marko; Jeftic, Nikola; Besu, Irina; Raketic, Jovan; Markovic, Ivan; Djuric, Ana; Petrovic, Nina; Srdic-Rajic, Tatjana
铁死亡
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Pioneering first-in-class HDAC-ROCK inhibitors as potential multitarget anticancer agents.

开创性的首创 HDAC-ROCK 抑制剂作为潜在的多靶点抗癌药物

期刊:Future Medicinal Chemistry
影响因子:3.4
doi:10.1080/17568919.2025.2459589
Beljkas Milan, Ruzic Dusan, Djuric Ana, Vuletic Ana, Tchiehe Guilaine Nchugoua, Jallet Corinne, Cadet-Daniel Véronique, Arimondo Paola B, Santibanez Juan F, Srdic-Rajic Tatjana, Nikolic Katarina, Oljacic Slavica, Petkovic Milos
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Development of Novel ROCK Inhibitors via 3D-QSAR and Molecular Docking Studies: A Framework for Multi-Target Drug Design

通过三维定量构效关系（3D-QSAR）和分子对接研究开发新型ROCK抑制剂：多靶点药物设计的框架

期刊:Pharmaceutics
影响因子:5.5
doi:10.3390/pharmaceutics16101250
Beljkas, Milan; Petkovic, Milos; Vuletic, Ana; Djuric, Ana; Santibanez, Juan Francisco; Srdic-Rajic, Tatjana; Nikolic, Katarina; Oljacic, Slavica
3D/类器官
ROCK
发表日期：2024
文献求助 收藏

Correlating Basal Gene Expression across Chemical Sensitivity Data to Screen for Novel Synergistic Interactors of HDAC Inhibitors in Pancreatic Carcinoma

将基础基因表达与化学敏感性数据关联起来，以筛选胰腺癌中 HDAC 抑制剂的新型协同相互作用物

期刊:Pharmaceuticals
影响因子:
doi:10.3390/ph16020294
Nemanja Djokovic, Ana Djuric, Dusan Ruzic, Tatjana Srdic-Rajic, Katarina Nikolic
肿瘤
胰腺癌
发表日期：2023
文献求助 收藏

Discovery of 1-Benzhydryl-Piperazine-Based HDAC Inhibitors with Anti-Breast Cancer Activity: Synthesis, Molecular Modeling, In Vitro and In Vivo Biological Evaluation

发现具有抗乳腺癌活性的 1-苯二基哌嗪类 HDAC 抑制剂：合成、分子建模、体外和体内生物学评价

期刊:Pharmaceutics
影响因子:4.9
doi:10.3390/pharmaceutics14122600
Dusan Ruzic, Bernhard Ellinger, Nemanja Djokovic, Juan F Santibanez, Sheraz Gul, Milan Beljkas, Ana Djuric, Arasu Ganesan, Aleksandar Pavic, Tatjana Srdic-Rajic, Milos Petkovic, Katarina Nikolic
肿瘤
乳腺癌
发表日期：2022
文献求助 收藏

Antibody Epitope Specificity for dsDNA Phosphate Backbone Is an Intrinsic Property of the Heavy Chain Variable Germline Gene Segment Used

抗体表位特异性针对双链DNA磷酸骨架，是所用重链可变种系基因片段的固有属性。

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2018.02378
Srdic-Rajic, Tatjana; Kohler, Heinz; Jurisic, Vladimir; Metlas, Radmila
发表日期：2018
文献求助 收藏

Author Correction: Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells

作者更正：Iscador Qu抑制阿霉素诱导的MCF7细胞衰老

期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-018-31450-1
Srdic-Rajic, Tatjana; Santibañez, Juan F; Kanjer, Ksenija; Tisma-Miletic, Nevena; Cavic, Milena; Galun, Daniel; Jevric, Marko; Kardum, Nevena; Konic-Ristic, Aleksandra; Zoranovic, Tamara
细胞衰老
细胞生物学
衰老
发表日期：2018
文献求助 收藏

Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells

Iscador Qu 抑制阿霉素诱导的 MCF7 细胞衰老

期刊:Scientific Reports
影响因子:3.8
doi:10.1038/s41598-017-03898-0
Tatjana Srdic-Rajic, Juan F Santibañez, Ksenija Kanjer, Nevena Tisma-Miletic, Milena Cavic, Daniel Galun, Marko Jevric, Nevena Kardum, Aleksandra Konic-Ristic, Tamara Zoranovic
免疫
细胞生物学
其它细胞
Senescence
发表日期：2017
文献求助 收藏

Targeted therapy and personalized medicine in hepatocellular carcinoma: drug resistance, mechanisms, and treatment strategies

肝细胞癌的靶向治疗和个体化医疗：耐药性、机制和治疗策略

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S106529
Galun, Danijel; Srdic-Rajic, Tatjana; Bogdanovic, Aleksandar; Loncar, Zlatibor; Zuvela, Marinko
细胞生物学
肿瘤
肿瘤免疫
发表日期：2017
文献求助 收藏

Biological evaluation of transdichloridoplatinum(II) complexes with 3- and 4-acetylpyridine in comparison to cisplatin

对反式二氯铂(II)与3-和4-乙酰吡啶形成的配合物与顺铂的生物学评价

期刊:Radiology and Oncology
影响因子:2.2
doi:10.2478/raon-2013-0050
Filipovic, Lana; Arandelovic, Sandra; Gligorijevic, Nevenka; Krivokuca, Ana; Jankovic, Radmila; Srdic-Rajic, Tatjana; Rakic, Gordana; Tesic, Zivoslav; Radulovic, Sinisa
发表日期：2013
文献求助 收藏